Valiant Co Ltd
SZSE:002643
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.75
16.59
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Valiant Co Ltd
Valiant Co Ltd
Total Liabilities & Equity
Valiant Co Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Valiant Co Ltd
SZSE:002643
|
Total Liabilities & Equity
¥10.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
21%
|
|
|
Shanghai Putailai New Energy Technology Co Ltd
SSE:603659
|
Total Liabilities & Equity
¥41.9B
|
CAGR 3-Years
32%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
Total Liabilities & Equity
¥294.2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
25%
|
CAGR 10-Years
23%
|
|
|
Hoshine Silicon Industry Co Ltd
SSE:603260
|
Total Liabilities & Equity
¥87.9B
|
CAGR 3-Years
49%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
C
|
CNGR Advanced Material Co Ltd
SZSE:300919
|
Total Liabilities & Equity
¥62.2B
|
CAGR 3-Years
85%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
|
Tianqi Lithium Corp
SZSE:002466
|
Total Liabilities & Equity
¥69.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
7%
|
CAGR 10-Years
26%
|
|
Valiant Co Ltd
Glance View
Valiant Co Ltd., an unassuming powerhouse in the world of specialty chemicals, operates with the precision of a seasoned craftsman. Founded in the vibrant economic landscape of China, this company carved its niche by focusing on the production of organic intermediates and additives that are crucial to a multitude of industries, from pharmaceuticals to electronics. At the heart of Valiant’s operation is its cutting-edge R&D department, which serves as the crucible for innovation and competitive advantage. By investing heavily in research and development, Valiant ensures that its products not only meet but anticipate the evolving demands of its clients, consistently delivering high-quality, high-value solutions that enhance the performance of their customers’ end products. Valiant Co Ltd.’s revenue model is as robust as it is strategic. With a diversified portfolio, it taps into several high-growth sectors, thus buffering itself against market volatility. The company primarily generates its revenue through the sale of its specialized chemical products worldwide. By maintaining long-term contracts and strong partnerships with industry leaders, Valiant is able to ensure a steady stream of income. Furthermore, its extensive distribution network amplifies its reach, thereby maximizing its market penetration. By providing bespoke solutions and reliable delivery, Valiant cements its position as an indispensable partner to its clients, which not only fortifies its revenue streams but also burnishes its reputation in the competitive world of specialty chemicals.
See Also
What is Valiant Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
10.5B
CNY
Based on the financial report for Sep 30, 2024, Valiant Co Ltd's Total Liabilities & Equity amounts to 10.5B CNY.
What is Valiant Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
21%
Over the last year, the Total Liabilities & Equity growth was 5%. The average annual Total Liabilities & Equity growth rates for Valiant Co Ltd have been 13% over the past three years , 13% over the past five years , and 21% over the past ten years .
You don't have any saved screeners yet
